Innovations In Cancer Therapy Inc is categorized under Professional Organizations in Beverly, MA and active since 2010.
Innovations In Cancer Therapy Inc was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Professional Organizations business, which does work in the B2B market, and is classified as a Professional Organizations, under code number 813920 by the NAICS.
If you are seeking more information, feel free to contact Carol Cyr at the company’s single location by writing to 900 Cummings Center # 221u, Beverly, Massachusetts MA 01915 or by phoning (978) 927-8330. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovations In Cancer Therapy Inc |
| Contact Person: | Carol Cyr |
| Address: | 900 Cummings Center # 221u, Beverly, Massachusetts 01915 |
| Phone Number: | (978) 927-8330 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Professional Organizations |
| SIC Code: | 8621 |
| NAICS Code: | 813920 |
| Share This Business: |
Innovations In Cancer Therapy Inc was started in 2010 to provide professional Professional Organizations under the SIC code 8621 and NAICS code 813920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Carol Cyr for inquiries that concern Innovations In Cancer Therapy Inc by calling the company number (978) 927-8330, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovations In Cancer Therapy Inc can be found at the coordinates 42.560942,-70.887082 as well as the street address 900 Cummings Center # 221u in Beverly, Massachusetts 01915.
For its online presence, you may visit Innovations In Cancer Therapy Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.